Simon J. Steddon

Quality Improvement: Supporting a hospital in difficulty: experience of a ‘buddying’ agreement to implement a new medical pathway

Richard Leach, Sandip Banerjee, G. De Beer, Svetka Tencheva et autres

Increased NHS regulation has identified many healthcare organisations with operational and/or financial difficulties. Although the causes are often complex, most cases are effectively managed internally with limited input from external agencies. How best to support the few organisations needing additional support has …

gb, ca (code pays fourni par la source)

Acute kidney injury (AKI)

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John M. Cunningham

Chronic kidney disease (CKD)

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John M. Cunningham

The NKF KDOQI (National Kidney Foundation Kidney Dialysis Outcomes Quality Initiative) classification of chronic kidney disease (CKD) has been rapidly adopted internationally.1 It is simple and useful and has help to raise awareness of kidney disease. CKD is divided into five stages, …

Diseases of the kidney

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John M. Cunningham

Renal physiology

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John M. Cunningham

Dialysis

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John M. Cunningham

Essential urology

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John Alastair Cunningham

Transplantation

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John Alastair Cunningham

Appendices

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John Alastair Cunningham

Temporary haemodialysis catheters should be temporary—ideally no line should remain in situ for longer than a few days. The risk of infection increases significantly if in place for longer—consider switching to a tunnelled line if continuing access is required ( p. 296). …

Drugs and the kidney

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John Alastair Cunningham

Always verify the recommended dose and dosing schedule when prescribing for a patient with renal impairment. Ask yourself, ‘Is the drug still warranted, given the potential increased risk?’. Renal impairment may alter the sensitivity of target tissue to the effects of drugs. …

Hypertension

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John Alastair Cunningham

Extract Hypertension facts and figures Epidemiology The WHO identifies hypertension as the single most important preventable cause of premature death in developed countries. It is the most common indication for prescription drug therapy (in 2009, the NHS in the UK funded 140 …

The kidney in systemic disease

Simon J. Steddon, Neil Ashman, Alistair M S Chesser, John Alastair Cunningham

Diabetic nephropathy (DN) is one of the most significant complications of diabetes mellitus. It is the leading cause of CKD (and ESRD) in the western world, and its incidence is rising in developing countries. This increase has been driven by the increased …